Vanda Pharmaceuticals Stock Price on October 16, 2024
| VNDA Stock | USD 4.81 0.01 0.21% |
Below is the normalized historical share price chart for Vanda Pharmaceuticals extending back to April 12, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vanda Pharmaceuticals stands at 4.81, as last reported on the 26th of March, with the highest price reaching 4.87 and the lowest price hitting 4.74 during the day.
If you're considering investing in Vanda Stock, it is important to understand the factors that can impact its price. At this point, Vanda Pharmaceuticals is slightly risky. Vanda Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0122, which indicates the firm had a 0.0122 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Vanda Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate Vanda Pharmaceuticals' Semi Deviation of 2.31, risk adjusted performance of 0.0256, and Coefficient Of Variation of 4454.42 to confirm if the risk estimate we provide is consistent with the expected return of 0.0305%.
At present, Vanda Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 689 M, whereas Common Stock Total Equity is forecasted to decline to about 39.5 K. . As of March 26, 2025, Price To Sales Ratio is expected to decline to 1.33. In addition to that, Price Earnings Ratio is expected to decline to -15.47. Vanda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of April 2006 | 200 Day MA 4.9234 | 50 Day MA 4.797 | Beta 0.767 |
Vanda |
Sharpe Ratio = 0.0122
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VNDA |
Estimated Market Risk
| 2.49 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vanda Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vanda Pharmaceuticals by adding Vanda Pharmaceuticals to a well-diversified portfolio.
Price Book 0.5219 | Enterprise Value Ebitda 12.9072 | Price Sales 1.4141 | Shares Float 52.5 M | Wall Street Target Price 10.43 |
Related Headline
Cullinan Oncology Headline on 16th of October 2024
Cullinan gets FDA clearance for Phase 1 lupus study for CLN-... by seekingalpha.com
Cullinan Therapeutics said the FDA has cleared its application for a Phase 1 study of its drug candidate CLN-978 for the treatment of lupus. Read more here.
Vanda Pharmaceuticals Valuation on October 16, 2024
It is possible to determine the worth of Vanda Pharmaceuticals on a given historical date. On October 16, 2024 Vanda was worth 4.84 at the beginning of the trading date compared to the closed value of 4.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vanda Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Vanda Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vanda Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vanda Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 4.78 | 4.88 | 4.68 | 4.80 | 1,006,229 | |
10/16/2024 | 4.84 | 4.98 | 4.80 | 4.90 | 494,551 |
| 4.90 | 4.90 | 4.72 | 4.74 | 396,028 |
| Backtest Vanda Pharmaceuticals | | | Vanda Pharmaceuticals History | | | Vanda Pharmaceuticals Valuation | Previous | Next |
Vanda Pharmaceuticals Trading Date Momentum on October 16, 2024
| On October 17 2024 Vanda Pharmaceuticals was traded for 4.74 at the closing time. The top price for the day was 4.90 and the lowest listed price was 4.72 . The trading volume for the day was 396 K. The trading history from October 17, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.27% . The trading price change against the current closing price is 6.33% . |
Vanda Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Vanda Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vanda Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vanda financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vanda Pharmaceuticals Stock history
Vanda Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vanda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vanda Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vanda Pharmaceuticals stock prices may prove useful in developing a viable investing in Vanda Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 58.1 M | 48.1 M | |
| Net Income Applicable To Common Shares | 7.2 M | 8.4 M |
Vanda Pharmaceuticals Quarterly Net Working Capital |
|
Vanda Pharmaceuticals Stock Technical Analysis
Vanda Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vanda Pharmaceuticals Period Price Range
Low | March 26, 2025
| High |
0.00 | 0.00 |
Vanda Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vanda Pharmaceuticals March 26, 2025 Market Strength
Market strength indicators help investors to evaluate how Vanda Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vanda Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vanda Pharmaceuticals stock market strength indicators, traders can identify Vanda Pharmaceuticals entry and exit signals to maximize returns
Vanda Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vanda Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vanda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vanda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0256 | |||
| Jensen Alpha | 0.0447 | |||
| Total Risk Alpha | 0.038 | |||
| Sortino Ratio | 0.0182 | |||
| Treynor Ratio | 0.0803 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |